Key Highlights: Implications: If completed, the transaction would likely be a strong validation event for mid-sized Indian pharmaceutical businesses that combine branded generics, nu...
Key Highlights: Implications: The FTC is allowing Aurobindo’s $250 million Lannett deal only with a divestiture remedy, which should keep competition intact in four generic drug ...
